2012Contemporary MedicineRequires access

Effect of transcatheter hepatic arterial chemoembolization Oilin treatment of liver cancer patients with portal vein tumor thrombus

Qing Zhang

Open publisher page 0 citations

Abstract

Objective To explore the effect of transcatheter hepatic artery chemoembolization(TACE) in treatment of liver cancer patients with different types of portal vein tumor thrombus(PVTT).Methods The 413 patients with liver cancer and PVTT were divided into two groups,TACE(332 cases)group and control group(81 cases)to compare the survival rate and the curative effect of two group.Results Survival rate in the TACE group of 3 months,6 months,12 months,24 months were 93.4%,71.7%,44.9%,24.4%,in the control group 3 months,6 months,12 months,24 months survival rate were 24.7%,2.5%.0,0.The difference had statistical significance(P0.01).In the TACE group,type I,Ⅱ,Ⅲ,IV of PVTT patients treated with TACE also had different survival rate and different curative effect(P0.01).Conclusion TACE treatment is particularly effective for type I,type Ⅱ and type III patients of PVTT.

About this research paper

What this paper is about

Objective To explore the effect of transcatheter hepatic artery chemoembolization(TACE) in treatment of liver cancer patients with different types of portal vein tumor thrombus(PVTT).Methods The 413 patients with liver cancer and PVTT were divided into two groups,TACE(332 cases)group and control group(81 cases)to compare the survival rate and the curative effect of two group.Results Survival rate in the TACE group of 3 months,6 months,12 months,24 months were 93.4%,71.7%,44.9%,24.4%,in the control group 3 months,6 months,12 months,24 months survival rate were 24.7%,2.5%.0,0.The difference had statistical significance(P0.01).In the TACE group,type I,Ⅱ,Ⅲ,IV of PVTT patients treated with TACE also had different survival rate and different curative effect(P0.01).Conclusion TACE treatment is particularly effective for type I,type Ⅱ and type III patients of PVTT.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of transcatheter hepatic artery chemoembolization(TACE) in treatment of liver cancer patients with different types of portal vein tumor thrombus(PVTT).Methods The 413 patients with liver cancer and PVTT were divided into two groups,TACE(332 cases)group and control group(81 cases)to compare the survival rate and the curative effect of two group.Results Survival rate in the TACE group of 3 months,6 months,12 months,24 months were 93.4%,71.7%,44.9%,24.4%,in the control group 3 months,6 months,12 months,24 months survival rate were 24.7%,2.5%.0,0.The difference had statistical significance(P0.01).In the TACE group,type I,Ⅱ,Ⅲ,IV of PVTT patients treated with TACE also had different survival rate and different curative effect(P0.01).Conclusion TACE treatment is particularly effective for type I,type Ⅱ and type III patients of PVTT.

Key concepts: Medicine, Transcatheter arterial chemoembolization, Portal vein, Gastroenterology, Survival rate, Thrombus, Liver cancer, Artery

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of transcatheter hepatic arterial chemoembolization Oilin treatment of liver cancer patients with portal vein tumor thrombus — Research Paper | ScholarLens